TSL Express Daily News

SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Blue Spark Technologies, Inc. (“Blue Spark” or the “Company”) in the sale of substantially all assets to BST Technology Acquisition, Inc. The transaction closed in March 2025.

Blue Spark Technologies is a medical technology company focused on developing innovative, wearable vital sign monitoring devices. The Company’s flagship product, TempTraq®, is a wireless continuous temperature monitoring single-use patch that transmits real-time and historical data, via Bluetooth, for up to 72 hours. TempTraq® is FDA and CE cleared and was internally developed using the Company’s proprietary technology surrounding flexible, thin-printed batteries and biosensors.

From its inception in 2002, Blue Spark has been innovating continuous vital sign monitoring solutions that improve patient care and outcomes, reduce readmissions, and optimize hospital reimbursements. TempTraq® has proven successful in clinical studies and is actively used by hospitals and pharmaceutical companies. The Company’s extensive research, product development, and testing efforts shifted toward commercialization, which required a financial partner to support the sales cycle and increase wider adoption.

SSG was retained in October 2024 to explore strategic alternatives, including new investment or a sale of the Company. SSG’s comprehensive marketing process attracted significant interest from both strategic and financial investors who engaged in a thorough review of the business and proprietary technology portfolio. BST Technology Acquisition, Inc. provided the best option to partner with Blue Spark and maximize value for all stakeholders.

SSG’s special situations expertise and experience in the medical device sector resulted in a process that preserved jobs and positioned Blue Spark to advance its commercialization efforts under new ownership.

BST Technology Acquisition, Inc. is a medical technology holding company founded by representatives of SunBridge Partners, specifically to acquire the assets of Blue Spark.

SunBridge Partners is a venture capital firm founded in 2004 as part of Japan-based SunBridge, specializing in cofounding and scaling Japan subsidiaries of global tech companies and making early-stage investments in the U.S. and Japan.

Other professionals who worked on the transaction include:

• Michael P. O’Neil, Howard Bobrow, Brandi N. Weekley, Jennifer E. Horn, and Hakmat Manaa of Taft Stettinius & Hollister LLP, counsel to BST Technology Acquisition, Inc.;
• Maureen S. Dixon and Matthew Kita of Kirkland & Ellis LLP, counsel to the Secured Creditor; and
• Paul Coloma and Mason K. Stage of Alvarez & Marsal North America LLC, financial advisor to the Insurer Group.